lofentanil has been researched along with diprenorphine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, V; Burns, HD; Dannals, RF; Duelfer, T; Frost, JJ; Langström, B; Ravert, HT; Wagner, HN | 1 |
| Chen, C; Claude, PA; Law, PY; Liu-Chen, LY; Luo, LY; Xue, JC; Yin, J; Zhu, J | 1 |
| Butour, JL; Meunier, JC; Moisand, C; Mollereau, C; Parmentier, M | 1 |
3 other study(ies) available for lofentanil and diprenorphine
| Article | Year |
|---|---|
In vivo studies of opiate receptors.
Topics: Brain; Carbon Radioisotopes; Diprenorphine; Drug Compounding; Fentanyl; Humans; Radioactive Tracers; Receptors, Opioid; Structure-Activity Relationship; Tomography, Emission-Computed | 1984 |
The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
Topics: Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Diprenorphine; Fentanyl; Kinetics; Protein Binding; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Recombinant Fusion Proteins; Structure-Activity Relationship; Substrate Specificity; Sufentanil | 1996 |
Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids.
Topics: Adenylyl Cyclase Inhibitors; Animals; Binding, Competitive; Cell Membrane; CHO Cells; Cricetinae; Diprenorphine; Dynorphins; Etorphine; Fentanyl; Glutamine; Histamine; Humans; Kinetics; Ligands; Naltrexone; Narcotic Antagonists; Narcotics; Nociceptin; Nociceptin Receptor; Opioid Peptides; Receptors, Opioid | 1996 |